Multiple sclerosis is a chronic inflammatory neurodegenerative disorder which directly affects Central Nervous System CNS . People with MS suffer with an episodic reversible memory loss during the initial stages and later it leads to the neurological deterioration. Number of research and studies has been done on the natural compounds and phytochemical compounds in order to develop the particular drug for the treatment of MS in vivo andin vitro. The present study focuses on the inhibitory effect of Rosmarinic acid against the effect of CD2 Associated protein with the help of Molecular Docking. Molecular Docking basically screens the ligand and the target protein and shows the interaction between them on the basis of the minimum binding affinities and drug likeliness properties. In our research, docking was performed between CD2 Associated protein and selected ligands with the help of docking software. Ligands were selected on the basis of their minimum Binding affinities and finally by their drug likeliness properties. Rosmarinic acid BA 5.6 was the resultant ligand of our recent study. It showed the perfect interaction with CD2 Associated protein. Therefore, we may conclude that Rosmarinic acid may act as a compound which may be used as a drug for the treatment of multiple sclerosis fromfurther in vitro and in vivostudies in future. Jitin Kumar | Tejaswee Anand | Ritika Sharma | Noopur Khare | Abhimanyu Kumar Jha | Yamini Dixit "A Possible Role of Rosmarinic Acid against CD2-Associated Protein for the Treatment of Multiple Sclerosis through in Silico Approach" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-5 , August 2021, URL: https://www.ijtsrd.com/papers/ijtsrd44979.pdf Paper URL: https://www.ijtsrd.com/biological-science/biotechnology/44979/a-possible-role-of-rosmarinic-acid-against-cd2associated-protein-for-the-treatment-of-multiple-sclerosis-through-in-silico-approach/jitin-kumar
International Journal of Trend in Scientific Research and Development (IJTSRD)
Volume 5 Issue 5, July-August 2021 Available Online: www.ijtsrd.com e-ISSN: 2456 – 6470
@ IJTSRD | Unique Paper ID – IJTSRD44979 | Volume – 5 | Issue – 5 | Jul-Aug 2021
Page 1171
A Possible Role of Rosmarinic Acid against CD2-Associated Protein
for the Treatment of Multiple Sclerosis through in Silico Approach
Jitin Kumar
1
, Tejaswee Anand
1
, Ritika Sharma
1
,
Noopur Khare
2
, Abhimanyu Kumar Jha
1
, Yamini Dixit
1
1Department of Biotechnology, Faculty of Life Sciences, Institute of
Applied Medicines and Research, Ghaziabad, Uttar Pradesh, India
2Shri Ramswaroop Memorial University, Barabanki, Uttar Pradesh, India
ABSTRACT
Multiple sclerosis is a chronic inflammatory neurodegenerative
disorder which directly affects Central Nervous System (CNS).
People with MS suffer with an episodic reversible memory loss
during the initial stages and later it leads to the neurological
deterioration. Number of research and studies has been done on the
natural compounds and phytochemical compounds in order to
develop the particular drug for the treatment of MS in-vivo &in-
vitro. The present study focuses on the inhibitory effect of
Rosmarinic acid against the effect of CD2 Associated protein with
the help of Molecular Docking. Molecular Docking basically screens
the ligand and the target protein and shows the interaction between
them on the basis of the minimum binding affinities and drug
likeliness properties. In our research, docking was performed
between CD2-Associated protein and selected ligands with the help
of docking software. Ligands were selected on the basis of their
minimum Binding affinities and finally by their drug likeliness
properties. Rosmarinic acid (BA- -5.6) was the resultant ligand of our
recent study. It showed the perfect interaction with CD2-Associated
protein. Therefore, we may conclude that Rosmarinic acid may act as
a compound which may be used as a drug for the treatment of
mul